STERIS Cash And Equivalents vs Net Tangible Assets Analysis
STE Stock | USD 216.41 6.79 3.24% |
STERIS Plc financial indicator trend analysis is much more than just breaking down STERIS plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether STERIS plc is a good investment. Please check the relationship between STERIS Plc Cash And Equivalents and its Net Tangible Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.
Cash And Equivalents vs Net Tangible Assets
Cash And Equivalents vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of STERIS plc Cash And Equivalents account and Net Tangible Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between STERIS Plc's Cash And Equivalents and Net Tangible Assets is -0.45. Overlapping area represents the amount of variation of Cash And Equivalents that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of STERIS plc, assuming nothing else is changed. The correlation between historical values of STERIS Plc's Cash And Equivalents and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Equivalents of STERIS plc are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Cash And Equivalents i.e., STERIS Plc's Cash And Equivalents and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | -0.45 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Cash And Equivalents
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from STERIS Plc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into STERIS plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.At present, STERIS Plc's Enterprise Value is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 4.6B | 5.0B | 5.1B | 5.4B | Depreciation And Amortization | 553.1M | 552.9M | 565.2M | 593.5M |
STERIS Plc fundamental ratios Correlations
Click cells to compare fundamentals
STERIS Plc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
STERIS Plc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 5.4B | 6.6B | 11.5B | 10.8B | 11.1B | 11.6B | |
Short Long Term Debt Total | 1.2B | 1.7B | 3.1B | 3.1B | 3.4B | 3.6B | |
Other Current Liab | 281.2M | 335.7M | 379.5M | 395.0M | 478.1M | 502.0M | |
Total Current Liabilities | 503.6M | 577.9M | 922.2M | 861.8M | 931.1M | 977.7M | |
Total Stockholder Equity | 3.4B | 3.9B | 6.5B | 6.1B | 6.3B | 6.6B | |
Property Plant And Equipment Net | 1.2B | 1.4B | 1.7B | 1.9B | 1.9B | 2.0B | |
Net Debt | 830.9M | 1.4B | 2.8B | 2.8B | 3.2B | 3.3B | |
Retained Earnings | 1.6B | 1.9B | 2.0B | 1.9B | 2.1B | 2.2B | |
Accounts Payable | 149.3M | 157.0M | 225.7M | 279.6M | 251.7M | 264.3M | |
Cash | 319.6M | 220.5M | 348.3M | 208.4M | 207.0M | 126.3M | |
Non Current Assets Total | 4.2B | 5.4B | 9.6B | 8.8B | 8.2B | 8.6B | |
Cash And Short Term Investments | 319.6M | 220.5M | 348.3M | 208.4M | 207.0M | 126.3M | |
Net Receivables | 586.5M | 609.4M | 799.0M | 928.3M | 1.0B | 1.1B | |
Common Stock Shares Outstanding | 85.6M | 85.9M | 98.3M | 100.2M | 99.4M | 73.9M | |
Liabilities And Stockholders Equity | 5.4B | 6.6B | 11.5B | 10.8B | 11.1B | 11.6B | |
Non Current Liabilities Total | 1.5B | 2.1B | 4.0B | 3.9B | 3.8B | 4.0B | |
Inventory | 248.3M | 315.1M | 575.0M | 695.5M | 674.5M | 708.3M | |
Other Current Assets | 54.4M | 66.8M | 156.6M | 179.3M | 979.3M | 1.0B | |
Other Stockholder Equity | 12.8M | 10.5M | 12.3M | 10.0M | 9.0M | 8.5M | |
Total Liab | 2.0B | 2.7B | 4.9B | 4.7B | 4.7B | 5.0B | |
Total Current Assets | 1.2B | 1.2B | 1.9B | 2.0B | 2.9B | 3.0B | |
Short Term Debt | 19.8M | 22.8M | 179.3M | 95.0M | 117.2M | 123.0M | |
Intangible Assets | 565.5M | 898.4M | 3.3B | 3.0B | 2.1B | 2.2B | |
Non Currrent Assets Other | 51.6M | 52.7M | 70.7M | 78.1M | 66.2M | 69.5M | |
Accumulated Other Comprehensive Income | (235.5M) | (61.2M) | (209.8M) | (320.7M) | (328.7M) | (312.2M) | |
Common Stock | 2.0B | 2.0B | 4.7B | 4.5B | 4.5B | 4.8B | |
Other Liab | 250.6M | 454.5M | 1.0B | 693.7M | 797.7M | 837.6M | |
Other Assets | 51.6M | 52.7M | 70.7M | 78.1M | 1.0 | 0.95 | |
Long Term Debt | 1.2B | 1.7B | 2.9B | 3.0B | 3.1B | 3.3B | |
Good Will | 2.4B | 3.0B | 4.4B | 3.9B | 4.1B | 4.3B | |
Property Plant Equipment | 1.2B | 1.2B | 1.7B | 1.7B | 2.0B | 2.1B | |
Current Deferred Revenue | 53.3M | 62.5M | 110.8M | 92.3M | 70.5M | 68.8M | |
Common Stock Total Equity | 2.0B | 2.0B | 2.0B | 4.5B | 5.2B | 5.4B | |
Property Plant And Equipment Gross | 1.2B | 1.4B | 1.7B | 1.7B | 3.5B | 3.7B | |
Net Tangible Assets | 472.3M | 854.9M | (1.2B) | 2.2B | 2.5B | 2.7B | |
Long Term Debt Total | 1.2B | 1.7B | 2.9B | 3.0B | 3.5B | 1.8B | |
Deferred Long Term Liab | 151.0M | 160.3M | 236.9M | 617.5M | 710.2M | 745.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.305 | Dividend Share 2.13 | Earnings Share 6.15 | Revenue Per Share 53.903 | Quarterly Revenue Growth 0.073 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.